Syngene International

Update in progress

SYNGENE.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

Syngene International Limited is a contract research and manufacturing organization offering end-to-end drug discovery, development, and manufacturing services. It covers discovery chemistry, biology, DMPK, safety assessment, analytical, formulation, and clinical development, plus pharmacovigilance and medical writing. Serving pharma, biotech, animal health, and related sectors, it collaborates with major companies and is a Biocon subsidiary founded in 1993 and based in Bengaluru, India.

Company score

Sentiment: 0.53; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.10; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.44; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.18; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.33; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive